Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Halleck

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Transplantation Proceedings|December 5, 2017
Long-Term Outcomes of Kidney Transplant Recipients With Primary Idiopathic Focal Segmental GlomerulosclerosisO Staeck, F Halleck, K Budde, et al.
Transplantation Proceedings|December 5, 2017
Prolonged Low-Dose Prophylaxis With Valganciclovir in Cytomegalovirus-Negative Recipients of Kidney Transplants From Cytomegalovirus-Positive Donors Allows Seroconversion and Prevents Cytomegalovirus DiseaseF Halleck, D Khadzhynov, E Schrezenmeier, et al.
Transplantation Proceedings|December 5, 2017
Immunologic Long-term Outcomes of Living-Related Kidney Transplantations Depending on the Donor-Recipient RelationshipD Khadzhynov, F Halleck, L Lehner, et al.
Transplantation Proceedings|December 5, 2017
Incidence of Infectious Disease and Malignancies After Rituximab Therapy in Kidney Transplant Recipients: Results From a Cohort in GermanyE Schrezenmeier, K Budde, O Staeck, et al.
Transplantation Proceedings|April 30, 2013
New perspectives of immunosuppressionF Halleck, F Friedersdorff, T F Fuller, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 26, 2016
Successful Recovery of Acute Renal Transplant Failure in Recurrent Hepatitis C Virus-Associated Membranoproliferative GlomerulonephritisE Schrezenmeier, K Wu, F Halleck, et al.
Der Urologe. Ausg. A|October 14, 2015
[Immunosuppression and its use in kidney transplantation]A Paliege, J Bamoulid, F Bachmann, et al.
Transplantation Proceedings|December 23, 2018
Impact of Pre-existing Comorbidities on Long-term Outcomes in Kidney Transplant RecipientsA Kleinsteuber, F Halleck, D Khadzhynov, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 15, 2017
Donor-Recipient Matching Based on Predicted Indirectly Recognizable HLA Epitopes Independently Predicts the Incidence of De Novo Donor-Specific HLA Antibodies Following Renal TransplantationN Lachmann, M Niemann, P Reinke, et al.
World Journal of Urology|January 9, 2013
Pre-operative assessment of living renal transplant donors with state-of-the-art imaging modalities: computed tomography angiography versus magnetic resonance angiography in 118 patientsF Engelken, F Friedersdorff, T F Fuller, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Transplantation Proceedings|December 5, 2017
Long-Term Outcomes of Kidney Transplant Recipients With Primary Idiopathic Focal Segmental GlomerulosclerosisO Staeck, F Halleck, K Budde, et al.
Transplantation Proceedings|December 5, 2017
Prolonged Low-Dose Prophylaxis With Valganciclovir in Cytomegalovirus-Negative Recipients of Kidney Transplants From Cytomegalovirus-Positive Donors Allows Seroconversion and Prevents Cytomegalovirus DiseaseF Halleck, D Khadzhynov, E Schrezenmeier, et al.
Transplantation Proceedings|December 5, 2017
Immunologic Long-term Outcomes of Living-Related Kidney Transplantations Depending on the Donor-Recipient RelationshipD Khadzhynov, F Halleck, L Lehner, et al.
Transplantation Proceedings|December 5, 2017
Incidence of Infectious Disease and Malignancies After Rituximab Therapy in Kidney Transplant Recipients: Results From a Cohort in GermanyE Schrezenmeier, K Budde, O Staeck, et al.
Transplantation Proceedings|April 30, 2013
New perspectives of immunosuppressionF Halleck, F Friedersdorff, T F Fuller, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 26, 2016
Successful Recovery of Acute Renal Transplant Failure in Recurrent Hepatitis C Virus-Associated Membranoproliferative GlomerulonephritisE Schrezenmeier, K Wu, F Halleck, et al.
Der Urologe. Ausg. A|October 14, 2015
[Immunosuppression and its use in kidney transplantation]A Paliege, J Bamoulid, F Bachmann, et al.
Transplantation Proceedings|December 23, 2018
Impact of Pre-existing Comorbidities on Long-term Outcomes in Kidney Transplant RecipientsA Kleinsteuber, F Halleck, D Khadzhynov, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 15, 2017
Donor-Recipient Matching Based on Predicted Indirectly Recognizable HLA Epitopes Independently Predicts the Incidence of De Novo Donor-Specific HLA Antibodies Following Renal TransplantationN Lachmann, M Niemann, P Reinke, et al.
World Journal of Urology|January 9, 2013
Pre-operative assessment of living renal transplant donors with state-of-the-art imaging modalities: computed tomography angiography versus magnetic resonance angiography in 118 patientsF Engelken, F Friedersdorff, T F Fuller, et al.
Pageof 2